- Home
- GT vs CPRX Comparison
GT vs CPRX Comparison
Compare GT & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GT
- CPRX
- Stock Information
- Founded
- GT 1898
- CPRX 2002
- Country
- GT United States
- CPRX United States
- Employees
- GT N/A
- CPRX N/A
- Industry
- GT Automotive Aftermarket
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- GT Consumer Discretionary
- CPRX Health Care
- Exchange
- GT Nasdaq
- CPRX Nasdaq
- Market Cap
- GT 2.4B
- CPRX 2.5B
- IPO Year
- GT N/A
- CPRX 2006
- Fundamental
- Price
- GT $9.26
- CPRX $22.92
- Analyst Decision
- GT Buy
- CPRX Strong Buy
- Analyst Count
- GT 3
- CPRX 7
- Target Price
- GT $13.30
- CPRX $32.86
- AVG Volume (30 Days)
- GT 4.8M
- CPRX 1.4M
- Earning Date
- GT 02-10-2025
- CPRX 02-26-2025
- Dividend Yield
- GT N/A
- CPRX N/A
- EPS Growth
- GT N/A
- CPRX 114.68
- EPS
- GT N/A
- CPRX 1.18
- Revenue
- GT $19,047,000,000.00
- CPRX $460,482,000.00
- Revenue This Year
- GT N/A
- CPRX $23.98
- Revenue Next Year
- GT N/A
- CPRX $18.27
- P/E Ratio
- GT N/A
- CPRX $19.45
- Revenue Growth
- GT N/A
- CPRX 32.17
- 52 Week Low
- GT $7.27
- CPRX $13.12
- 52 Week High
- GT $14.97
- CPRX $24.27
- Technical
- Relative Strength Index (RSI)
- GT 52.37
- CPRX 57.64
- Support Level
- GT $8.47
- CPRX $21.23
- Resistance Level
- GT $9.61
- CPRX $23.26
- Average True Range (ATR)
- GT 0.33
- CPRX 1.15
- MACD
- GT 0.09
- CPRX 0.20
- Stochastic Oscillator
- GT 69.83
- CPRX 77.73
About GT The Goodyear Tire & Rubber Company
Goodyear Tire & Rubber Co manufactures and sells a variety of rubber tires under the Goodyear brand name. The firm's tires are used for automobiles, trucks, buses, aircraft, motorcycles, mining equipment, farm equipment, and industrial equipment. The company operates its business through three operating segments representing its regional tire businesses: Americas; Europe, the Middle East, and Africa (EMEA); and the Asia Pacific.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.